Report Detail

Pharma & Healthcare Global Sevoflurane (Sevoflurane Source) Market Insights, Forecast to 2025

  • RnM2850497
  • |
  • 01 February, 2019
  • |
  • Global
  • |
  • 117 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Sevoflurane is a halogenated general inhalation anesthetic drug. It’s a volatile liquid for inhalation, a nonflammable and nonexplosive liquid administered by vaporization.
As Chinese technology is developing fast, Chinese Sevoflurane market is predicted to be growing fast.
Despite the presence of competition problems, due to the global recovery trend is clear, investors are still optimistic about this area; the future will still have more new investment entering the field.
The global Sevoflurane (Sevoflurane Source) market is valued at 1060 million US$ in 2018 and will reach 1280 million US$ by the end of 2025, growing at a CAGR of 2.5% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Sevoflurane (Sevoflurane Source) market based on company, product type, end user and key regions.

This report studies the global market size of Sevoflurane (Sevoflurane Source) in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Sevoflurane (Sevoflurane Source) in these regions.
This research report categorizes the global Sevoflurane (Sevoflurane Source) market by top players/brands, region, type and end user. This report also studies the global Sevoflurane (Sevoflurane Source) market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Abbott(AbbVie)
Baxter
Maruishi Pharmaceutical
Shanghai Hengrui
BeiTe

Market size by Product
Human Series
Animal Series
Market size by End User
Hospitals
Other Medical Institutions

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Sevoflurane (Sevoflurane Source) market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Sevoflurane (Sevoflurane Source) market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Sevoflurane (Sevoflurane Source) companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Sevoflurane (Sevoflurane Source) submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Sevoflurane (Sevoflurane Source) are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (Pcs). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Sevoflurane (Sevoflurane Source) market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


Table of Contents

    1 Study Coverage

    • 1.1 Sevoflurane (Sevoflurane Source) Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Sevoflurane (Sevoflurane Source) Market Size Growth Rate by Product
      • 1.4.2 Human Series
      • 1.4.3 Animal Series
    • 1.5 Market by End User
      • 1.5.1 Global Sevoflurane (Sevoflurane Source) Market Size Growth Rate by End User
      • 1.5.2 Hospitals
      • 1.5.3 Other Medical Institutions
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Sevoflurane (Sevoflurane Source) Market Size
      • 2.1.1 Global Sevoflurane (Sevoflurane Source) Revenue 2014-2025
      • 2.1.2 Global Sevoflurane (Sevoflurane Source) Sales 2014-2025
    • 2.2 Sevoflurane (Sevoflurane Source) Growth Rate by Regions
      • 2.2.1 Global Sevoflurane (Sevoflurane Source) Sales by Regions
      • 2.2.2 Global Sevoflurane (Sevoflurane Source) Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Sevoflurane (Sevoflurane Source) Sales by Manufacturers
      • 3.1.1 Sevoflurane (Sevoflurane Source) Sales by Manufacturers
      • 3.1.2 Sevoflurane (Sevoflurane Source) Sales Market Share by Manufacturers
      • 3.1.3 Global Sevoflurane (Sevoflurane Source) Market Concentration Ratio (CR5 and HHI)
    • 3.2 Sevoflurane (Sevoflurane Source) Revenue by Manufacturers
      • 3.2.1 Sevoflurane (Sevoflurane Source) Revenue by Manufacturers (2014-2019)
      • 3.2.2 Sevoflurane (Sevoflurane Source) Revenue Share by Manufacturers (2014-2019)
    • 3.3 Sevoflurane (Sevoflurane Source) Price by Manufacturers
    • 3.4 Sevoflurane (Sevoflurane Source) Manufacturing Base Distribution, Product Types
      • 3.4.1 Sevoflurane (Sevoflurane Source) Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Sevoflurane (Sevoflurane Source) Product Type
      • 3.4.3 Date of International Manufacturers Enter into Sevoflurane (Sevoflurane Source) Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Sevoflurane (Sevoflurane Source) Sales by Product
    • 4.2 Global Sevoflurane (Sevoflurane Source) Revenue by Product
    • 4.3 Sevoflurane (Sevoflurane Source) Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Sevoflurane (Sevoflurane Source) Breakdown Data by End User

    6 North America

    • 6.1 North America Sevoflurane (Sevoflurane Source) by Countries
      • 6.1.1 North America Sevoflurane (Sevoflurane Source) Sales by Countries
      • 6.1.2 North America Sevoflurane (Sevoflurane Source) Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Sevoflurane (Sevoflurane Source) by Product
    • 6.3 North America Sevoflurane (Sevoflurane Source) by End User

    7 Europe

    • 7.1 Europe Sevoflurane (Sevoflurane Source) by Countries
      • 7.1.1 Europe Sevoflurane (Sevoflurane Source) Sales by Countries
      • 7.1.2 Europe Sevoflurane (Sevoflurane Source) Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Sevoflurane (Sevoflurane Source) by Product
    • 7.3 Europe Sevoflurane (Sevoflurane Source) by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Sevoflurane (Sevoflurane Source) by Countries
      • 8.1.1 Asia Pacific Sevoflurane (Sevoflurane Source) Sales by Countries
      • 8.1.2 Asia Pacific Sevoflurane (Sevoflurane Source) Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Sevoflurane (Sevoflurane Source) by Product
    • 8.3 Asia Pacific Sevoflurane (Sevoflurane Source) by End User

    9 Central & South America

    • 9.1 Central & South America Sevoflurane (Sevoflurane Source) by Countries
      • 9.1.1 Central & South America Sevoflurane (Sevoflurane Source) Sales by Countries
      • 9.1.2 Central & South America Sevoflurane (Sevoflurane Source) Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Sevoflurane (Sevoflurane Source) by Product
    • 9.3 Central & South America Sevoflurane (Sevoflurane Source) by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Sevoflurane (Sevoflurane Source) by Countries
      • 10.1.1 Middle East and Africa Sevoflurane (Sevoflurane Source) Sales by Countries
      • 10.1.2 Middle East and Africa Sevoflurane (Sevoflurane Source) Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Sevoflurane (Sevoflurane Source) by Product
    • 10.3 Middle East and Africa Sevoflurane (Sevoflurane Source) by End User

    11 Company Profiles

    • 11.1 Abbott(AbbVie)
      • 11.1.1 Abbott(AbbVie) Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Abbott(AbbVie) Sevoflurane (Sevoflurane Source) Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 Abbott(AbbVie) Sevoflurane (Sevoflurane Source) Products Offered
      • 11.1.5 Abbott(AbbVie) Recent Development
    • 11.2 Baxter
      • 11.2.1 Baxter Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Baxter Sevoflurane (Sevoflurane Source) Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Baxter Sevoflurane (Sevoflurane Source) Products Offered
      • 11.2.5 Baxter Recent Development
    • 11.3 Maruishi Pharmaceutical
      • 11.3.1 Maruishi Pharmaceutical Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 Maruishi Pharmaceutical Sevoflurane (Sevoflurane Source) Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Maruishi Pharmaceutical Sevoflurane (Sevoflurane Source) Products Offered
      • 11.3.5 Maruishi Pharmaceutical Recent Development
    • 11.4 Shanghai Hengrui
      • 11.4.1 Shanghai Hengrui Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Shanghai Hengrui Sevoflurane (Sevoflurane Source) Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Shanghai Hengrui Sevoflurane (Sevoflurane Source) Products Offered
      • 11.4.5 Shanghai Hengrui Recent Development
    • 11.5 BeiTe
      • 11.5.1 BeiTe Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 BeiTe Sevoflurane (Sevoflurane Source) Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 BeiTe Sevoflurane (Sevoflurane Source) Products Offered
      • 11.5.5 BeiTe Recent Development

    12 Future Forecast

    • 12.1 Sevoflurane (Sevoflurane Source) Market Forecast by Regions
      • 12.1.1 Global Sevoflurane (Sevoflurane Source) Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Sevoflurane (Sevoflurane Source) Revenue Forecast by Regions 2019-2025
    • 12.2 Sevoflurane (Sevoflurane Source) Market Forecast by Product
      • 12.2.1 Global Sevoflurane (Sevoflurane Source) Sales Forecast by Product 2019-2025
      • 12.2.2 Global Sevoflurane (Sevoflurane Source) Revenue Forecast by Product 2019-2025
    • 12.3 Sevoflurane (Sevoflurane Source) Market Forecast by End User
    • 12.4 North America Sevoflurane (Sevoflurane Source) Forecast
    • 12.5 Europe Sevoflurane (Sevoflurane Source) Forecast
    • 12.6 Asia Pacific Sevoflurane (Sevoflurane Source) Forecast
    • 12.7 Central & South America Sevoflurane (Sevoflurane Source) Forecast
    • 12.8 Middle East and Africa Sevoflurane (Sevoflurane Source) Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Sevoflurane (Sevoflurane Source) Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      Summary:
      Get latest Market Research Reports on Sevoflurane (Sevoflurane Source) . Industry analysis & Market Report on Sevoflurane (Sevoflurane Source) is a syndicated market report, published as Global Sevoflurane (Sevoflurane Source) Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Sevoflurane (Sevoflurane Source) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,900.00
      $5,850.00
      $7,800.00
      3,006.90
      4,510.35
      6,013.80
      3,611.40
      5,417.10
      7,222.80
      597,636.00
      896,454.00
      1,195,272.00
      328,887.00
      493,330.50
      657,774.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report